Back to search

Article

Impact of APOE Genotype on Neurocognition Following Conformal Whole Brain Radiotherapy for Brain Metastases: A Post hoc Analysis of Phase II Randomized Trial

2025-05-19

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> The genetic risk of radiotherapy-induced cognitive decline (RICD) in patients undergoing whole-brain radiotherapy (WBRT) has not been clearly established. Apolipoprotein E (APOE) polymorphisms, known to influence cognitive aging and Alzheimer’s disease risk, may also modulate neurocognitive outcomes after cranial irradiation. This post-hoc analysis investigate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b4a91642-a04f-5e23-bcf8-b95b59b88ecc
DOI
10.21203/rs.3.rs-6431871/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of APOE Genotype on Neurocognition Following Conformal Whole Brain Radiotherapy for Brain Metastases: A Post hoc Analysis of Phase II Randomized TrialDOI 10.21203/rs.3.rs-6431871/v1
Select a neighboring publication to make it the new centre.